Ultragenyx Pharmaceutical Inc.
RARE
$21.34
-$0.37-1.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.48% | -30.00% | -36.17% | 19.99% | 5.68% |
| Total Receivables | 28.00% | 22.34% | 17.62% | 2.38% | 67.81% |
| Inventory | 15.56% | 20.46% | 15.85% | 28.20% | 32.47% |
| Prepaid Expenses | 53.33% | -- | -- | -- | -32.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 85.71% | -81.69% | -82.76% | -82.16% | 248.61% |
| Total Current Assets | 16.40% | -19.56% | -25.38% | 17.31% | 11.58% |
|
|
|||||
| Total Current Assets | 16.40% | -19.56% | -25.38% | 17.31% | 11.58% |
| Net Property, Plant & Equipment | -8.56% | -8.25% | -8.23% | -8.49% | -7.14% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -0.91% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -0.91% |
| Total Other Intangibles | -1.12% | 4.85% | 5.11% | 6.96% | 7.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 7.40% | 11.81% | 4.01% | 9.52% |
| Total Assets | 1.93% | -22.62% | -19.29% | 0.37% | 0.80% |
|
|
|||||
| Total Accounts Payable | -20.51% | 12.73% | -42.75% | 15.81% | -7.39% |
| Total Accrued Expenses | 9.96% | 19.19% | 17.08% | 16.01% | 22.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.00% | 31.33% | 28.98% | 22.34% | 43.41% |
| Total Finance Division Other Current Liabilities | 75.00% | -74.44% | -- | -- | -- |
| Total Other Current Liabilities | 75.00% | -74.44% | -- | -- | -- |
| Total Current Liabilities | 11.63% | 19.30% | 7.47% | 18.77% | 22.67% |
|
|
|||||
| Total Current Liabilities | 11.63% | 19.30% | 7.47% | 18.77% | 22.67% |
| Long-Term Debt | 39.88% | -7.95% | -7.05% | -6.44% | -4.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.00% | -8.31% | -4.70% | -0.69% | -1.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.38% | 5.74% | 4.86% | 5.94% | 11.21% |
| Total Liabilities | 29.33% | -0.87% | -3.21% | -0.53% | 2.09% |
|
|
|||||
| Common Stock & APIC | 5.65% | 5.81% | 6.09% | 14.96% | 15.03% |
| Retained Earnings | -14.53% | -15.17% | -14.44% | -15.44% | -16.81% |
| Treasury Stock & Other | 200.00% | -8.48% | 75.53% | 20.88% | -254.56% |
| Total Common Equity | -131.37% | -97.36% | -65.01% | 2.84% | -7.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -131.37% | -97.36% | -65.01% | 2.84% | -7.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 0.00% | -- | -- | -- |
| Total Equity | -127.86% | -95.43% | -63.40% | 7.83% | -4.87% |
|
|
|||||